Skip to content

Ora Biomedical

Skincare actives found by worm lifespan screening

Raised to date

$205K

of $1M offered across 1 Form D filing

Still open
$795K
Investors
5
Last filed
Nov 13, 2026

About

Ora Biomedical is a Seattle company, founded by University of Washington aging researchers, that screens compounds for their effect on lifespan using WormBot, a robotic C. elegans platform. It has tested about 10,000 compounds and uses the results to develop botanical skincare actives and a topical treatment for radiation dermatitis. Longevity medicine is its longer-term goal.

One of the largest whole-organism lifespan datasets generated on a single platform under one protocol, around 10,000 compounds.

Funding

  • EquityFiled Nov 13, 2026Form D
    $205K/ $1M

Product

WormBot platform

Drug discovery screening platform

A robotic screening platform that combines automation, computer vision and machine learning to measure compound effects on lifespan in C. elegans.

  • Automated handling and continuous imaging of large animal populations
  • Computer vision and models that call and rank hits and fit dose-response
  • OraGen model retrained after every screen

Built for

Skincare brands, pharma partners and cancer-care developers

People on file